Myoscience
Latest round
- Series G
Last raised
- Mar 2018
Total raised
- $106M
Investors
- 6
About Myoscience
Myoscience, Inc. develops innovative non-opioid pain relief solutions, utilizing advanced cold technology to provide effective pain management.Myoscience, Inc. is a company that specializes in advanced pain management technologies. Founded in 2005, it is headquartered in Fremont, US, and has undergone a strategic shift with its acquisition by Pacira Pharmaceuticals, Inc. in March 2019 for USD 120 mn, with an additional USD 100 mn contingent on achieving commercial and regulatory milestones.Myoscience, Inc. is recognized for its flagship product, iovera°, a revolutionary treatment that employs advanced cold technology to deliver immediate and long-lasting pain relief. This treatment specifically targets peripheral nerve tissue to disrupt pain signals, making it a viable option for patients suffering from osteoarthritis (OA) knee pain and those exploring alternatives to knee replacement surgery. iovera° is FDA-cleared, safe, and can be administered in a variety of healthcare settings, including outpatient departments and ambulatory surgery centers. In addition to its knee applications, iovera° is also effective for pain relief in other regions such as the hip, shoulder, spine, foot, and ankle, and is indicated for conditions like rib fractures and post-mastectomy pain.Myoscience, Inc. generates revenue through the provision of iovera° and its associated services. The revenue model is based on direct transactions with healthcare providers, who integrate iovera° into their pain management protocols. Hospitals and clinics purchase the iovera° system and consumables, allowing them to offer this non-opioid treatment to their patients. Pricing is generally determined per treatment session or device usage, reflecting the advanced nature of the technology and its clinical benefits.Looking ahead, Myoscience, Inc. aims to leverage its recent acquisition by Pacira Pharmaceuticals, Inc. to enhance its product portfolio and expand market reach. This includes ongoing development of new pain relief products based on the iovera° technology. Additionally, Myoscience intends to broaden its market presence, particularly in the United States, to improve access to its non-opioid pain management solutions across various healthcare settings.
Who invested in Myoscience
6 investors across 7 rounds
See all investors in Myoscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series G
Mar 5, 2018
Amount
$31M
Investors
Series E
Sep 30, 2013
Amount
$10M
Investors
Series D
Mar 21, 2012
Amount
$33M
Investors
Series C
Mar 16, 2011
Amount
$19M
Investors
Series B
Oct 13, 2008
Amount
$1.1M
Investors
Series B
Jun 5, 2008
Amount
$8.7M
Investors
Series A
Apr 12, 2006
Amount
$3.3M
Investors
Questions about Myoscience
Who invested in Myoscience?
Myoscience has 6 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myoscience raised?
Myoscience has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Myoscience last raise money?
Myoscience's most recent round on record is a Series G, in Mar 2018.
What does Myoscience do?
Myoscience is a healthcare company.
Where is Myoscience headquartered?
Myoscience is headquartered in Fremont, US.
Which VCs invest in companies like Myoscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Myoscience's stage. Their profiles are linked below.
VCs backing healthcare startups at Series G
Raising like Myoscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.